Humana Inc. (NYSE:HUM) Given Consensus Recommendation of “Hold” by Brokerages

Shares of Humana Inc. (NYSE:HUM) have received a consensus recommendation of “Hold” from the thirty research firms that are covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, fifteen have issued a hold rating and fourteen have given a buy rating to the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is $403.9130.

Several equities analysts recently issued reports on the company. Zacks Research cut Humana from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 11th. Leerink Partners upgraded Humana from a “market perform” rating to an “outperform” rating and set a $513.00 target price on the stock in a research note on Thursday, July 30th. Royal Bank Of Canada boosted their target price on Humana from $246.00 to $415.00 and gave the company a “sector perform” rating in a report on Thursday, July 9th. Robert W. Baird set a $390.00 price objective on shares of Humana in a research report on Thursday, July 30th. Finally, JPMorgan Chase & Co. raised their target price on shares of Humana from $316.00 to $393.00 and gave the stock a “neutral” rating in a research note on Monday, August 10th.

Institutional Investors Weigh In On Humana

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Manning & Napier Advisors LLC purchased a new position in shares of Humana during the 2nd quarter worth $1,412,000. Mitsubishi UFJ Asset Management Co. Ltd. boosted its stake in Humana by 4.1% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 250,330 shares of the insurance provider’s stock worth $66,207,000 after buying an additional 9,960 shares during the last quarter. Sustainable Insight Capital Management LLC grew its holdings in Humana by 23.7% in the 4th quarter. Sustainable Insight Capital Management LLC now owns 24,757 shares of the insurance provider’s stock valued at $6,341,000 after buying an additional 4,740 shares during the period. Pzena Investment Management LLC purchased a new position in shares of Humana during the 2nd quarter worth about $1,749,014,000. Finally, Swedbank AB boosted its position in shares of Humana by 6.2% in the fourth quarter. Swedbank AB now owns 111,803 shares of the insurance provider’s stock worth $28,636,000 after acquiring an additional 6,534 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Stock Up 1.2%

Shares of NYSE:HUM opened at $405.90 on Friday. The stock has a market cap of $48.74 billion, a P/E ratio of 38.40, a P/E/G ratio of 2.63 and a beta of 0.74. The firm has a fifty day moving average price of $388.11 and a 200 day moving average price of $295.27. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.74 and a quick ratio of 1.74. Humana has a 1-year low of $163.11 and a 1-year high of $428.88.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, beating analysts’ consensus estimates of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The company had revenue of $40.89 billion for the quarter, compared to analyst estimates of $40.58 billion. During the same period in the previous year, the business posted $6.27 earnings per share. Humana’s quarterly revenue was up 26.2% on a year-over-year basis. Sell-side analysts predict that Humana will post 9 EPS for the current year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 27th. Stockholders of record on Friday, October 30th will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Friday, October 30th. Humana’s dividend payout ratio (DPR) is currently 33.49%.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.